Qualigen Therapeutics Inc. buy melinda
Start price
26.02.18
/
50%
€631.40
Target price
27.08.18
€1,127.5
Performance (%)
-31.07%
End price
27.08.18
€435.23
Summary
This prediction ended on 27.08.18 with a price of €435.23. The BUY prediction by melinda for Qualigen Therapeutics Inc. performed very badly with a performance of -31.07%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Qualigen Therapeutics Inc. | -2.941% | -2.941% | -81.701% | -98.680% |
| iShares Core DAX® | -5.630% | -5.765% | 8.425% | 8.571% |
| iShares Nasdaq 100 | -8.559% | -13.005% | 17.297% | 28.853% |
| iShares Nikkei 225® | -9.576% | -9.058% | 3.827% | 0.117% |
| iShares S&P 500 | -6.631% | -7.103% | 17.407% | 31.169% |
According to melinda what are the pros and cons of Qualigen Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Ritter Pharmaceuticals Inc diskutieren
Mikroben
Ritter Pharmaceuticals, Inc. entwickelt neuartige Therapeutika, die den menschlichen Darm-microbiome modulieren Magen - Darm - diseases.It bietet RP-G28, ein Medikament zur Behandlung von Lactose intolerance.The Firma gegründet wurde von Andrew J. Ritter, 29 zur Behandlung von März 2004
(Laufzeit überschritten)
Stopped prediction by melinda for Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.72
22.11.22
22.11.22
-
22.11.23
22.11.23
-66.14%
23.11.23
23.11.23
Could be worthwhile Investment >10% per year
Qualigen Therapeutics Inc.
Start price
Target price
Perf. (%)
€3,057.6
03.04.17
03.04.17
€6,765.0
03.10.17
03.10.17
-73.08%
03.10.17
03.10.17
Could be worthwhile Investment >10% per year
Qualigen Therapeutics Inc.
Start price
Target price
Perf. (%)
€4,059.0
24.03.17
24.03.17
€7,892.5
30.03.17
30.03.17
-11.11%
30.03.17
30.03.17
Could be worthwhile Investment >10% per year